News

Filter

Current filters:

Malaysia

First Asian approval for ophthalmic drug Jetrea, in Malaysia

18-04-2014

Belgian biotech firm ThromboGenics NV revealed today that Jetrea (ocriplasmin) has been approved in Malaysia…

AlconAsia-PacificBiotechnologyJetreaMalaysiaNovartisOphthalmicsRegulationThromboGenics

Biologics reimbursement trends in Argentina, Brazil and Mexico

Biologics reimbursement trends in Argentina, Brazil and Mexico

23-12-2013

Novel biologics must demonstrate improvements in efficacy, safety and cost-benefit compared with currently…

Anti-Arthritics/RheumaticsArgentinaBiotechnologyBrazilMalaysiaMarkets & MarketingOncologyPricingSouth America

India’s Biocon spreads its wings, investing $161-million in Malaysian unit

28-10-2010

Bangalore, India-based biotech firm Biocon (BSE: 532523) is making a big foray into the Malaysian market,…

Asia-PacificBioconBiotechnologyFinancialMalaysiaResearch

Agilent in deal with government of Malaysia to cooperate in biotechnology

05-08-2010

Agilent Technologies says it has signed a memorandum of understanding (MoU) with the government of Malaysia…

AgilentAsia-PacificBiotechnologyMalaysiaResearch

Back to top